Picture of M1 Kliniken AG logo

M12 — M1 Kliniken AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSuper Stock

Aesthetic clinic operator M1 Kliniken H1 revenue falls as HAEMATO Pharm disposal cuts trading sales

Aesthetic clinic operator M1 Kliniken H1 revenue falls as HAEMATO Pharm disposal cuts trading sales


Overview

  • Germany aesthetic medicine provider's Beauty segment H1 revenue grew 11%, EBIT up 23.8% yr/yr

  • Group revenue fell sharply after trading business sale; results not fully comparable yr/yr

  • Company completed exit from trading segment, now focused on Beauty clinic expansion


Outlook

  • M1 Kliniken targets Beauty segment revenue of EUR 200-300 mln by 2029

  • Company aims for a sustainable EBIT margin of at least 20% in Beauty segment

  • M1 Kliniken plans to expand national and international clinics to drive growth


Result Drivers

  • EFFICIENCY GAINS - Co said improved operating processes supported Beauty segment performance

  • MEDICAL CAPACITY EXPANSION - Targeted expansion of medical capacity contributed to Beauty segment growth

  • TRADING SEGMENT EXIT - Sharp decline in trading business results due to sale of HAEMATO Pharm GmbH and exit from trading segment


Company press release: ID:nEQc5LG3sa


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

H1 Revenue

EUR 76.60 mln

H1 EBIT

EUR 15.60 mln

H1 EBITDA

EUR 17.70 mln


Analyst Coverage

  • The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the healthcare facilities & services peer group is "buy."

  • Wall Street's median 12-month price target for M1 Kliniken AG is €29.00, about 43.2% above its September 8 closing price of €20.25

  • The stock recently traded at 17 times the next 12-month earnings vs. a P/E of 17 three months ago


Reuters Recommended Reads

  • Sept 7 - Audi introduces new compact EV in bid to boost European sales


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on M1 Kliniken AG

See all news